Condor Capital Management Viatris Inc Transaction History

Condor Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$12.09 - $14.68 $140,606 - $170,728	-11,630 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$13.25 - $15.13 $662 - $756	-50 Reduced 0.43%	11,630 $158,000
Q2 2021 Aug 11, 2021	BUY	$12.97 - $16.15 $713 - $888	55 Added 0.47%	11,680 $167,000
Q1 2021 May 10, 2021	SELL	$13.59 - $18.54 $81 - $111	-6 Reduced 0.05%	11,625 $162,000
Q4 2020 Jan 29, 2021	BUY	$14.3 - $18.74 $166,323 - $217,964	11,631 New	11,631 $218,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

Stay updated on Condor Capital Management with notifications on news.